WOBURN, Mass., Nov. 9, 2010 /PRNewswire/ — Cambridge Research
& Instrumentation, Inc. (CRi), a leader in multicolor imaging
solutions for preclinical and clinical research, today announced
the newest addition to the award-winning Nuance™
multispectral imaging product family for multicolor tissue and
cell-based imaging. The TRIO system is compact, multipurpose and
affordable, offering a simplified interface and versatile design to
fit any microscope with a camera-mount. This newest offering
strengthens CRi’s objective to offer a comprehensive and intuitive
solution that enables customers from basic research through
pre-clinical drug discovery to reveal correlations between protein
expression in intact tissue and clinical outcomes.
(Photo: http://photos.prnewswire.com/prnh/20101109/NE97171
)
(Photo: http://www.newscom.com/cgi-bin/prnh/20101109/NE97171
)
Multi-analyte detection from intact tissue and cells often poses
a challenge since overlapping signals and the sample’s own
background autofluorescence can mask critical information. TRIO’s
multispectral imaging technology found in all of CRi’s
multispectral systems effectively unmixes overlapping labels in
fluorescence or brightfield samples. It has a new easy-to-use
software interface designed to preclude the need to have
expert-level knowledge of multispectral imaging, a common hurdle
that faces many scientists who want to be able to image multiple
markers from a single tissue sample. TRIO’s interface ensures that
data can be obtained in a matter of minutes.
“Detecting multiple markers in intact tissue sections and in
individual tumor cells is an important component of targeted drug
and molecular diagnostic development,” said Darren Lee, Vice
President of Marketing at CRi. “We understand the hurdles
associated with doing multilabel imagin
‘/>”/>
SOURCE